tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

BioMarin Pharmaceutical Inc

BMRN
Add to Watchlist
63.940USD
-1.140-1.75%
Close 09-18 16:00（ET）
12.39BMarket Cap
45.89P/E TTM

BioMarin Pharmaceutical Inc

63.940
-1.140-1.75%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

BMRN Financials

See BioMarin Pharmaceutical Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
12.39B
Dividend TTM
0.00
P/E TTM
45.89
EPS TTM
1.40
Revenue
3.22B
Net Profit
426.86M
ROE
4.48%
ROA
3.42%

BioMarin Pharmaceutical Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
0.23/0.69
Revenue / Forecast
989.71M/926.91M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-81.54%0.23
-43.62%0.55
-136.98%-0.24
-128.74%-0.16
122.33%1.25
107.13%0.97
506.12%0.66
159.67%0.56
89.07%0.56
72.32%0.47
8167.16%0.11
--0.21
--0.30
--0.27
--0.00
--0.77
----
----
----
----
Revenue
19.91%989.71M
2.83%766.21M
17.03%874.57M
4.08%776.13M
15.92%825.41M
14.84%745.14M
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
20.22%646.21M
15.04%581.33M
11.52%595.27M
14.84%596.41M
19.50%537.54M
23.63%505.34M
6.40%533.80M
6.86%519.36M
-0.51%449.81M
-14.27%408.74M
Net Profit
-81.39%44.76M
-43.17%105.53M
-137.28%-46.57M
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
8282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
99.57%-249.00K
81.77%-6.65M
113.77%27.66M
595.40%120.80M
-361.99%-57.90M
-104.65%-36.49M
Net Margin
-84.48%4.52%
-44.73%13.77%
-131.85%-5.33%
-127.85%-3.96%
93.60%29.14%
82.36%24.92%
430.25%16.72%
104.80%14.22%
59.89%15.05%
60.27%13.66%
6907.02%3.15%
--6.95%
--9.41%
--8.53%
---0.05%
--9.10%
----
----
----
----
Gross Margin
-11.26%72.08%
-6.39%73.97%
1.32%81.55%
9.82%81.33%
1.96%81.23%
0.65%79.01%
5.50%80.49%
-1.62%74.06%
5.62%79.67%
3.09%78.50%
9.47%76.30%
--75.28%
--75.43%
--76.15%
--69.69%
--74.11%
----
----
----
----
Debt to assets ratio
346.60%35.71%
99.76%16.65%
-7.82%7.86%
-9.72%7.84%
-48.11%8.00%
-47.35%8.33%
-46.41%8.52%
-45.99%8.68%
-6.79%15.41%
-6.05%15.83%
-6.67%15.89%
--16.07%
--16.53%
--16.85%
--17.03%
--17.27%
----
----
----
----
Income Statement
Revenue
19.91%989.71M
2.83%766.21M
17.03%874.57M
4.08%776.13M
15.92%825.41M
14.84%745.14M
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
20.22%646.21M
15.04%581.33M
11.52%595.27M
14.84%596.41M
19.50%537.54M
23.63%505.34M
6.40%533.80M
6.86%519.36M
-0.51%449.81M
-14.27%408.74M
Operating profit
-39.56%167.34M
-38.39%137.94M
14.83%196.64M
-129.66%-46.69M
73.62%276.89M
185.35%223.89M
527.75%171.25M
415.70%157.42M
143.23%159.48M
27.75%78.46M
308.43%27.28M
2150.03%30.52M
63.72%65.57M
95.98%61.42M
79.61%-13.09M
97.10%-1.49M
188.88%40.05M
14.29%31.34M
-98.65%-64.19M
11.66%-51.40M
Net Profit
-81.39%44.76M
-43.17%105.53M
-137.28%-46.57M
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
8282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
99.57%-249.00K
81.77%-6.65M
113.77%27.66M
595.40%120.80M
-361.99%-57.90M
-104.65%-36.49M
Balance Sheet
Current assets
4.37%3.97B
32.79%4.61B
22.31%3.95B
26.11%3.85B
16.74%3.81B
16.18%3.47B
9.35%3.23B
3.43%3.06B
10.49%3.26B
5.03%2.99B
7.44%2.96B
10.16%2.96B
17.18%2.95B
18.72%2.84B
20.98%2.75B
16.06%2.68B
6.78%2.52B
4.60%2.39B
-2.90%2.27B
-15.60%2.31B
Total current liabilities
143.19%1.66B
26.26%793.15M
25.05%759.03M
11.57%798.44M
-35.89%684.25M
-42.25%628.21M
-48.43%606.99M
-38.48%715.66M
78.71%1.07B
81.85%1.09B
99.87%1.18B
123.26%1.16B
28.51%597.23M
21.98%598.23M
9.09%588.88M
1.19%521.02M
4.82%464.73M
14.04%490.42M
9.60%539.82M
-39.76%514.90M
Total assets
57.23%11.72B
20.20%8.59B
8.66%7.59B
11.15%7.61B
5.51%7.46B
3.99%7.15B
2.15%6.99B
1.38%6.85B
7.68%7.07B
6.82%6.87B
7.32%6.84B
7.89%6.76B
6.79%6.56B
6.12%6.43B
6.19%6.38B
4.79%6.26B
4.19%6.15B
4.44%6.06B
2.66%6.00B
-2.93%5.98B
Total liabilities
277.95%5.40B
75.75%2.38B
13.23%1.51B
8.37%1.56B
-19.74%1.43B
-24.76%1.35B
-29.58%1.33B
-22.75%1.44B
0.03%1.78B
1.36%1.80B
6.67%1.89B
9.78%1.86B
8.49%1.78B
6.18%1.77B
2.27%1.77B
-0.92%1.70B
-0.96%1.64B
1.73%1.67B
-0.54%1.73B
-18.67%1.71B
Total equity
4.89%6.32B
7.23%6.21B
7.58%6.09B
11.88%6.06B
14.01%6.03B
14.18%5.79B
14.27%5.66B
10.55%5.41B
10.53%5.29B
8.90%5.07B
7.57%4.95B
7.19%4.90B
6.17%4.78B
6.10%4.66B
7.78%4.60B
7.09%4.57B
6.21%4.50B
5.51%4.39B
4.01%4.27B
5.24%4.27B
Cash Flow Statement
Net operating income
-9.26%168.11M
26.52%220.65M
-46.32%99.64M
66.46%368.69M
56.00%185.27M
271.28%174.39M
575.42%185.63M
63.28%221.48M
69.51%118.76M
163.53%46.97M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-39.30%6.79M
63.12%158.32M
-32.08%56.23M
-140.02%-45.43M
183.53%11.18M
12.59%97.06M
Net investment
-40416.83%-5.10B
2669.33%725.53M
-155.56%-42.45M
-1948.42%-330.96M
-113.92%-12.59M
-98.36%-28.24M
217.61%76.40M
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-18.74%-64.96M
-95.71%-45.80M
199.43%29.53M
-134.19%-30.01M
1.28%-54.71M
80.47%-23.40M
75.30%-29.70M
224.01%87.78M
-602.59%-55.42M
-212.32%-119.85M
Net financing
59591.20%2.74B
2196.93%813.17M
10.42%3.16M
99.57%-2.17M
-136.50%-4.60M
9.38%-38.78M
-73.63%2.86M
-63240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.27%10.84M
-110.45%-788.00K
201.55%11.96M
-61.16%-40.74M
-24.50%10.87M
831.43%7.54M
-207.57%-11.78M
-3.76%-25.28M
103.93%14.40M
-131.66%-1.03M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its total revenue reached 3.22B, with a year-on-year change of 2.85B.

What are the current assets of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its current assets were 3.95B, with a year-on-year change of 22.31.

What are the total assets of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its total assets of BioMarin Pharmaceutical Inc were 7.59B, with a year-on-year change of 8.66.

What are the total liabilities of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its total liabilities of BioMarin Pharmaceutical Inc were 1.51B, with a year-on-year change of 13.23.

What is the total equity of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its total equity of BioMarin Pharmaceutical Inc was 6.09B, with a year-on-year change of 7.58.

What is the net operating income of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its net operating income of BioMarin Pharmaceutical Inc was 871.73M, with a year-on-year change of 52.92.

What is the net investment of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its net investment of BioMarin Pharmaceutical Inc was -414.24M, with a year-on-year change of -403.49.

What is the net financing of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its net financing of BioMarin Pharmaceutical Inc was -42.39M, with a year-on-year change of 91.95.

What is the Earnings Per Share (EPS) of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.82, with a year-on-year change of -19.01.

What is the net income of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its net income was 348.90M, with a year-on-year change of -18.26.

What is the net margin of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its net profit margin was 10.83, with a year-on-year change of -27.58.

What is the gross margin of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its gross margin was 80.83, with a year-on-year change of 3.42.

What is the debt-to-asset ratio of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its debt-to-asset ratio was 7.87, with a year-on-year change of -7.74.

What is the Return on Equity (ROE) of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its Return on Equity (ROE) was 5.94, with a year-on-year change of -26.17.

What is the Return on Assets (ROA) of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its Return on Assets (ROA) was 4.79, with a year-on-year change of -22.48.

What is the operating profit of BioMarin Pharmaceutical Inc?

According to BioMarin Pharmaceutical Inc's FY2025 earnings report, its operating profit was 871.73M, with a year-on-year change of 52.92.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy